A subject this map covers
Viral vector delivery
Part of: Gene therapy
What belongs here
Gene delivery by viral vector to the cord or to the neurons that reach it.
What does not belong here, however close it looks
Non-viral delivery — nanoparticles, electroporation — has its own concepts.
What has been looked at
Counted from what the sources catalogue, not from reading the work. It says how much exists and over what span of years — never what any of it found.
- Registered or indexed as work in people: 92 records · 1995–2026
- Indexed as work in animals: 246 records · 1998–2026
- Indexed as laboratory work: 13 records · 1997–2021
- The source has not said who or what was studied: 68 records · 1996–2026
- No clinical trial on this subject is registered for spinal cord injury.
- Nobody has yet checked any of this against its original for this map, so none of it is on the checked shelf.
Checked
Records a person has read against the original and published into this map. These carry measurements, evidence states and a place on the ladder.
Nobody has checked a record on this subject yet.
Checking is done by a person, one record at a time, and this subject has not reached the queue yet. The shelf below is what the sources hold in the meantime; it has not been read by anybody.
Found in the scientific sources, not yet checked
Titles and identifiers as the sources publish them. Nobody here has read these papers, and nothing on this shelf is a result, a recommendation or evidence that anything works. Each line opens the original.
419 records
This grouping is the source's own cataloguing, not a reading of the paper. It says where a record was filed, not what it found.
The source has not said who or what was studied
- AAV2retro Enters Axons of Passage and Extensively Transduces Corticospinal Neurons After Injection into Spinal White Matter. — PubMed · 2025 · Journal Article
- Therapeutic potential of 5HT2CR in alleviating spasticity and pain via modulation of motor neurons and interneurons in spinal cord injury. — PubMed · 2025 · Journal Article
- Combined strategy of α 9-integrin transduction and AEIDGIEL peptide-functionalized fibrin gel biomaterials to promote mature DRG neurite growth. — PubMed · 2025 · Journal Article
- Lentivirus-mediated overexpression of netrin-1/DCC co-expression promotes axonal regeneration and functional recovery in spinal cord injury via the inhibition of the NgR1-RhoA-ROCK signaling pathway. — PubMed · 2025 · Journal Article
- Adeno-associated virus (AAV) production and administration v1 — Crossref · 2024 · posted-content
- Mesenchymal stem cells overexpressing XIST induce macrophage M2 polarization and improve neural stem cell homeostatic microenvironment, alleviating spinal cord injury. — PubMed · 2024 · Journal Article
- Adeno-associated virus (AAV) gene therapy for spinal muscular atrophy — Crossref · 2023 · journal-article
- Adeno-associated virus (AAV) production and administration v1 — Crossref · 2023 · posted-content
- Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model. — PubMed · 2023 · Journal Article
- Boosters for adeno-associated virus (AAV) vector (r)evolution — Crossref · 2023 · journal-article
- Corrigendum: Hypoxia response element-directed expression of aFGF in neural stem cells promotes the recovery of spinal cord injury and attenuates SCI-induced apoptosis. — PubMed · 2022 · Published Erratum
- Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury. — PubMed · 2022 · Journal Article
- Inhibition of LncRNA Vof-16 expression promotes nerve regeneration and functional recovery after spinal cord injury. — PubMed · 2022 · Journal Article
- Nerve growth factor (NGF) with hypoxia response elements loaded by adeno-associated virus (AAV) combined with neural stem cells improve the spinal cord injury recovery. — PubMed · 2021 · Journal Article
- Repair of spinal cord injury in rats via exosomes from bone mesenchymal stem cells requires sonic hedgehog. — PubMed · 2021 · Journal Article
- Hypoxia Response Element-Directed Expression of aFGF in Neural Stem Cells Promotes the Recovery of Spinal Cord Injury and Attenuates SCI-Induced Apoptosis. — PubMed · 2021 · Journal Article
- Planet of the AAVs: The Spinal Cord Injury Episode. — PubMed · 2021 · Journal Article
- An Adeno-Associated Viral vector encoding Neurotrophin 3 injected into affected forelimb muscles modestly improves sensorimotor function after contusive mid-cervical spinal cord injury — Crossref · 2021 · posted-content
- Hypoxia response element-directed expression of bFGF in dental pulp stem cells improve the hypoxic environment by targeting pericytes in SCI rats. — PubMed · 2021 · Journal Article
- Bilateral Adeno-associated virus (AAV) injection into interscapular brown adipose tissue v1 — Crossref · 2020 · posted-content
- Ex Vivo Rat Transected Spinal Cord Slices as a Model to Assess Lentiviral Vector Delivery of Neurotrophin-3 and Short Hairpin RNA against NG2. — PubMed · 2020 · Journal Article
- Adeno-Associated Virus Vector Mediated Gene Delivery to Neurons and Glial Cells in Damaged Spinal Cord — Crossref · 2018 · book-chapter
- Adeno-Associated Virus (AAV) as a Vector for Gene Therapy — Crossref · 2017 · journal-article
- Adeno-Associated Virus (AAV) Vector and AAV Empty Particles — Crossref · 2017 · journal-article
- The Evaluation of Nerve Growth Factor Over Expression on Neural Lineage Specific Genes in Human Mesenchymal Stem Cells. — PubMed · 2016 · Journal Article
- 3D Imaging of Axons in Transparent Spinal Cords from Rodents and Nonhuman Primates. — PubMed · 2015 · Journal Article
- Overexpression of microRNA-124 promotes the neuronal differentiation of bone marrow-derived mesenchymal stem cells. — PubMed · 2014 · Journal Article
- 241. Vector Design Tour De Force: Integrating Combinatorial and Rational Approaches To Derive Novel Adeno-Associated Virus (AAV) Variants — Crossref · 2014 · journal-article
- Intraspinal AAV Injections Immediately Rostral to a Thoracic Spinal Cord Injury Site Efficiently Transduces Neurons in Spinal Cord and Brain. — PubMed · 2013 · Journal Article
- Silencing the gene encoding C/EBP homologous protein lessens acute brain injury following ischemia/reperfusion. — PubMed · 2012 · Journal Article
- Corrigendum to “Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood-Brain Barrier (BBB)” — Crossref · 2010 · journal-article
- Genotyping of AAV Plasmid Stocks: Quality Control in Adeno-Associated Virus Vector Production — Crossref · 2010 · journal-article
- Adeno-associated virus (AAV) vector–mediated gene transfer to induce long-lived antibodies against simian immunodeficiency virus (SIV) — Crossref · 2009 · journal-article
- Adeno-Associated Virus (AAV) — Crossref · 2008 · book-chapter
- Adeno‐Associated Virus ( <scp>AAV</scp> ) — Crossref · 2004 · other
- 1058. Adeno-Associated Virus Serotype 6 (AAV-6) Vector Mediated Gene Transfer of Soluble VEGF Receptors for the Treatment of Glioblastoma Multiforme — Crossref · 2004 · journal-article
- 342. Self-Complementary Adeno-Associated Virus 2 (AAV)-T Cell Protein Tyrosine Phosphatase Vector as a Helper-Virus To Improve Transduction Efficiency of Conventional AAV Vectors In Vitro and In Vivo — Crossref · 2004 · journal-article
- 92. Metabolically Biotinylated Adeno-Associated Virus (AAV) Types 1, 2, 3, 4 and 5 for Scalable Purification and Vector Retargeting — Crossref · 2004 · journal-article
- From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy — Crossref · 2003 · journal-article
- 37. Self-Complementary Adeno-Associated Virus Serotype 2 Vector: Global Distribution and Broad Dispersion of AAV-Mediated Transgene Expression in Mouse Brain — Crossref · 2003 · journal-article
- 898. Evaluation of the Potential of Recombinant Vector Genomes Based on Serotypes of Adeno-Associated Virus (AAV) for In Vivo Gene Transfer — Crossref · 2003 · journal-article
- Packaging of Human Chromosome 19-Specific Adeno-Associated Virus (AAV) Integration Sites in AAV Virions during AAV Wild-Type and Recombinant AAV Vector Production — Crossref · 2003 · journal-article
- Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord — Crossref · 2002 · journal-article
- Adeno-associated Virus and AAV Vectors for Gene Delivery — Crossref · 2000 · book-chapter
- The Use of Heterologous Promoters for Adeno‐Associated Virus (AAV) Protein Expression in AAV Vector Production — Crossref · 1998 · journal-article
- 5474935 Adeno-associated virus (AAV)-based eucaryotic vectors — Crossref · 1997 · journal-article
- 5474935 Adeno-associated virus (AAV)-based eucaryotic vectors — Crossref · 1997 · journal-article
- Adeno-associated Virus Based Vectors As Antivirals — Crossref · 1996 · book-chapter
- Biology of Adeno-associated Virus — Crossref · 1996 · book-chapter
- Packaging Systems for Adeno-associated Virus Vectors — Crossref · 1996 · book-chapter
- The Challenges of Recombinant Adeno-associated Virus Manufacturing: Alternative Use of Adeno-associated Virus Plasmid/Liposome Complexes for Gene Therapy Applications — Crossref · 1996 · book-chapter
- Adeno-Associated Virus (AAV) — Crossref · reference-entry
- Advancing adeno-associated virus (AAV) gene therapy for Duchenne muscular dystrophy — Crossref · dissertation
- Characterization of the non-structural proteins of adeno-associated virus (AAV) and minute virus of canine (MVC) — Crossref · dissertation
- Construction of Recombinant Adeno-Associated Virus (AAV) — Crossref · book-chapter
- Directed evolution of adeno associated virus (AAV) for retinal gene therapy — Crossref · dissertation
- EMPIAR dataset — Crossref
- Prevention and inhibition of adverse humoral immune response to gene therapy mediated by adeno-associated virus (AAV) vector — Crossref · dissertation
- Thermostability of Adeno-Associated Virus (AAV) Vectors — Crossref · dissertation
Where this was looked for, and when
The exact question each source was asked, the day it was asked, and what came back. A zero on this page is only honest if these are on it.
| ClinicalTrials.gov | asked, and it has nothing | asked on 2026-10-05 | the source found 0 · this programme has 0 · still to fetch 0 | aim: every record matching this question |
|---|---|---|---|---|
| Crossref | asked, and it answered | asked on 2026-09-17 | the source found 2898038 · this programme has 50 | aim: a sample of the most relevant records. This source ranks a bag of words, so its own total is the size of the corpus that shares some of them, never a set still owed. |
| PubMed | asked, and it answered | asked on 2026-09-17 | the source found 393 · this programme has 393 · still to fetch 0 | aim: every record matching this question |
The question asked
- ClinicalTrials.gov
("adeno-associated virus" OR "AAV vector" OR "lentiviral vector") - Crossref
spinal cord injury adeno-associated virus AAV vector - PubMed
("Spinal Cord Injuries"[MeSH Terms] OR "spinal cord injury"[Title/Abstract] OR "spinal cord injuries"[Title/Abstract] OR "spinal cord trauma"[Title/Abstract]) AND ("Dependovirus"[MeSH Terms] OR "Genetic Vectors"[MeSH Terms] OR "adeno-associated virus"[Title/Abstract] OR "AAV vector"[Title/Abstract] OR "lentiviral vector"[Title/Abstract])